SOM has licensed to the biotech ARGON Pharma a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.
SOM has licensed to the biotech ARGON Pharma a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.